BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38138979)

  • 1. Synthesis and Characterisation of Platinum(II) Diaminocyclohexane Complexes with Pyridine Derivatives as Anticancer Agents.
    McGhie BS; Sakoff J; Gilbert J; Gordon CP; Aldrich-Wright JR
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity.
    McGhie BS; Sakoff J; Gilbert J; Gordon CP; Aldrich-Wright JR
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
    Franich AA; Živković MD; Ilić-Tomić T; Đorđević IS; Nikodinović-Runić J; Pavić A; Janjić GV; Rajković S
    J Biol Inorg Chem; 2020 May; 25(3):395-409. PubMed ID: 32162071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl
    Hoeschele JD; Kasparkova J; Kostrhunova H; Novakova O; Pracharova J; Pineau P; Brabec V
    J Biol Inorg Chem; 2020 Sep; 25(6):913-924. PubMed ID: 32851480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
    Hajipour F; Mahdavinia M; Fereidoonnezhad M
    Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis(triazinyl)pyridine complexes of Pt(II) and Pd(II): studies of the nucleophilic substitution reactions, DNA/HSA interactions, molecular docking and biological activity.
    Jovanović-Stević S; Radisavljević S; Scheurer A; Ćoćić D; Šmit B; Petković M; Živanović MN; Virijević K; Petrović B
    J Biol Inorg Chem; 2021 Aug; 26(5):625-637. PubMed ID: 34268603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
    Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
    J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel platinum complexes of imidazolyl-containing bisphosphonates as potential anticancer agents.
    Qiu L; Lv G; Cao Y; Chen L; Yang H; Luo S; Zou M; Lin J
    J Biol Inorg Chem; 2015 Dec; 20(8):1263-75. PubMed ID: 26531104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
    Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
    Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appended Aromatic Moieties Determine the Cytotoxicity of Neutral Cyclometalated Platinum(II) Complexes Derived from 2-(2-Pyridyl)benzimidazole.
    Vaquero M; Busto N; Fernández-Pampín N; Espino G; García B
    Inorg Chem; 2020 Apr; 59(7):4961-4971. PubMed ID: 32182052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum(II) and palladium(II) complexes with 2-acetyl pyridine 4N-ethyl thiosemicarbazone able to overcome the cis-platin resistance. Structure, antibacterial activity and DNA strand breakage.
    Kovala-Demertzi D; Demertzis MA; Filiou E; Pantazaki AA; Yadav PN; Miller JR; Zheng Y; Kyriakidis DA
    Biometals; 2003 Sep; 16(3):411-8. PubMed ID: 12680703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
    Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line.
    Shams Abyaneh FS; Eslami Moghadam M; Divsalar A; Ajloo D; Hosaini Sadr M
    Appl Biochem Biotechnol; 2018 Oct; 186(2):271-291. PubMed ID: 29516403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, cytotoxicity, and DNA binding of some new platinum(II) and platinum(IV) complexes with benzimidazole ligands.
    Utku S; Gumus F; Tezcan S; Serin MS; Ozkul A
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):502-8. PubMed ID: 20233087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer.
    Eslami Moghadam M; Hasanzadeh Esfahani M; Behzad M; Zolghadri S; Ramezani N; Azadi Y
    J Biol Inorg Chem; 2023 Aug; 28(5):519-529. PubMed ID: 37452868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.